Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Coya Therapeutics, Inc. issued 2,522,727 shares of common stock to certain accredited investors (including Dr. Reddy's Labs and Greenlight Capital) for $4.40 per Share.
- Security
- common stock
- Shares
- 2,522,727 shares
- Purchaser
- certain accredited investors (including Dr. Reddy's Labs and Greenlight Capital)
- Consideration
- $4.40 per Share
Exact text from the filing
On January 29, 2026, Coya Therapeutics, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Securities Purchase Agreement ”) with certain accredited investors (collectively, the “ Purchasers ”) for the issuance and sale in a private placement of 2,522,727 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), at a purchase price of $4.40 per Share (the “ Offering ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Coya Therapeutics, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $11.1 million (effective 2026-01-29).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors
- Value
- approximately $11.1 million
- Effective
- 2026-01-29
Exact text from the filing
On January 29, 2026, Coya Therapeutics, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Securities Purchase Agreement ”) with certain accredited investors
View on SEC.gov